Balyasny Asset Management
PAND

Balyasny Asset Management’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Balyasny Asset Management’s Portfolio PAND Stock Details PAND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-402,364
Closed -$24.2M – 2643
2021
Q1 		$24.2M Buy
+402,364
New +$14.6M 0.12% 228

Balyasny Asset Management's PAND Position: Q2 2021 in Review

Balyasny Asset Management sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 402,364 shares — an estimated $24.2M sold.

Balyasny Asset Management first reported a position in PAND in Q1 2021 and held it in 1 quarter. The position peaked at $24.2M in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

  • Balyasny Asset Management reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Balyasny Asset Management sold 402,364 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $24.2M.
  • Balyasny Asset Management first reported a position in Pandion Therapeutics Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Balyasny Asset Management's Pandion Therapeutics Inc. Common Stock position peaked at $24.2M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Balyasny Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.